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Abstract
Sexually transmitted diseases (STDs) are among the most common infections. Their clini-
cal identification is difficult because STDs are often asymptomatic. Untreated infections 
with these pathogens can in time lead to serious consequences. It is documented that 
isolation of some of these bacteria from cultures is very difficult. Because there is a large 
number of STD pathogens which can generate coinfections, their simultaneous detection 
in a unique sample is very important. Multiplex polymerase chain reaction (PCR) is an 
advanced method of molecular biology which allows for simultaneous detection of mul-
tiple pathogens in the same sample. The advantages of the multiplex PCR method were 
assessed by various researchers by comparing the diagnosis results obtained with differ-
ent other conventional methods. The sensitivity and specificity of these methods were 
analyzed on different specimens in comparison to traditional methods, such as culture 
media or direct microscopic examination. These studies demonstrated beyond any doubt 
that the multiplex PCR system is highly effective in the detection of each of multiple STD 
pathogens depicted from a single specimen and argued for multiplex PCR superiority in 
terms of sensitivity and rapidity.
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1. Introduction
Sexually transmitted diseases (STDs) are an issue of great interest as they are among the 
most common of all infections. It is documented that STDs are more prevalent in economi-
cally underdeveloped populations. Only a few countries outside Western Europe and 
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North America have implemented monitoring systems for these infections. In the rest of 
the world, epidemiological studies are based on the results of samples provided by certain 
population segments (mainly symptomatic patients or prenatal controls) not necessarily rep-
resentative for the majority of the population. Usually, persons presenting obvious signs 
(secretions, lesions or pain) interrupt their sexual activity and seek medical help. Ironically, 
most often those who actually transmit these infections are asymptomatic or present mild 
symptoms [1].
It is well‐known that vaginal bacterial infections can induce human infertility, yet they are 
underestimated in infertility testing. Population screening and treatment of individuals pre-
senting unexplained infertility that are detected as STD‐infected persons seem appropriate in 
this context [2].
No STD can be regarded as an isolated problem since multiple infections are rather common 
and STD infections generally denote a high‐risk sexual behavior that often can be associated 
with more serious infections. It is therefore important to acknowledge that STDs are often 
asymptomatic or cause nonspecific symptoms and that periodical STD testing is crucial in 
limiting the risk of human immunodeficiency virus (HIV) infection. STD control could sig-
nificantly reduce HIV incidence worldwide, although the impact of interventions may vary 
depending on local epidemiological contexts. Analysis of data from several studies has sug-
gested that a better management of STD cases is more likely to reduce HIV incidence in the 
early stages of an epidemic, when HIV infections are concentrated in population groups with 
a high prevalence of other curable STDs [3].
A correct STD diagnosis is needed to prevent further spreading of such infections in the healthy 
population. Several techniques and laboratory methods for highlighting these  diseases were 
developed in the past decades. For instance, because of their high sensitivity, specificity and 
suitability for different types of samples, nucleic acid amplification tests (NAATs) are suitable 
for the diagnosis of urogenital infections. Lately, however, polymerase chain reaction (PCR) 
techniques are increasingly employed in such cases as they allow direct, sensitive, automated 
and usable detection of STD‐causing pathogens on all sample types and even the simultane-
ous detection of several STDs.
2. The most frequent causative agent of STDs
Chlamydia trachomatis is an intracellular human pathogen. C. trachomatis infection is the 
most common STD reported in Western Europe developed countries [4]. About 75% of all 
cases involve young people aged 15–24 years, being more common in women than in men. 
It infects the epithelial cells of the endocervix in women and the urethra in men. Infection 
with C.  trachomatis is often asymptomatic, especially in women, but presents a high risk for 
complications. The treatment is rather simple if early detected. Of note, the bacteria can be 
passed from mother to newborn during delivery [5].
Urogenital infection with C. trachomatis shows a broad spectrum of clinical manifestations, 
including urethritis, cervicitis and pelvic inflammatory disease (PID). Intense  mucosal 
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inflammation is characterized by erythema, swelling and mucous secretions caused by 
 mucopurulent cervicitis in women and nongonococcal urehtritis (NGU) in men. It is very 
important to diagnose these bacteria in early stages of infection and beginning treatment as 
soon as possible to prevent long‐term complications. It can persist in the genital tract for a 
long time, in a form that is resistant to immunodestruction; such symptoms are unnoticed in 
approximately 75–80% of women [6]. C. trachomatis genital infection significantly increases 
the risk of sequelae in the reproductive tract in women, including tubal deterioration, ecto-
pic pregnancy and miscarriage [7]. The role of the C. trachomatis infection in decreasing 
male fertility is also well‐known. Given the severity of the complications, several countries 
(e.g., France) made recommendations for screening these bacteria in asymptomatic young 
subjects [8].
Neisseria gonorrhoeae is the etiologic agent of gonorrhea, one of the most common sexually 
transmitted bacterial infections, producing more than 82 million new infections worldwide 
each year [9]. N. gonorrhoeae or gonorrhea is an aerobic Gram‐negative bacterium presenting 
itself in the form of diplococci. Along with C. trachomatis, it is the most prevalent sexually 
transmitted bacterial infection. It causes urogenital mucosa infections in men and women, 
being a serious cause of morbidity. The disease is characterized by purulent inflammation 
of the urogenital system mucosa. It is also presumed that gonorrhea infection may increase 
susceptibility to HIV and its transmission [10].
Neisseria gonorrhoeae has developed mechanisms to alter the epithelial barriers in order to 
reach subepithelial tissues and colonize in the host organism. Emergence and spread of 
multiresistant N. gonorrhoeae strains and the absence of an effective vaccine are major prob-
lems worldwide. Gonococcal endocarditis is a rare (1–2%) but serious disease that occurs in 
patients with disseminated gonococcal infections, which are also rare (0.3–5%) [11].
Several data indicate the involvement of the gonococci in miscarriages. Screening and medical 
management of the N. gonorrhoeae infection, including screening of women visiting abortion 
centers, have been proposed in order to identify associated risk factors and to assess the ben-
efits of systematic screening in avoiding complications [12].
Trichomonas vaginalis is the causative agent of trichomonosis, one of the nonviral STDs. This 
protozoan was first described in 1836 by Donné. Infection with this parasite can give birth 
to serious complications, especially in women. The spectrum of clinical presentation range 
from asymptomatic or slightly symptomatic, particularly in men, to severe vaginitis with 
abundant vaginal secretions in women [13]. Infections with this protozoan can lead to serious 
health problems such as infertility, preterm delivery, low birth weight [14, 15], susceptibil-
ity to cervical cancer [15] or increased prevalence of high risk human papillomavirus (HPV) 
infection [16]. Moreover, there is a strong association between T. vaginalis infection and acqui-
sition of HIV [17]. Because it is sexually transmitted, trichomoniasis is common in popula-
tions at higher risk for other sexually transmitted infections. Its presence in an individual is 
a marker for high‐risk behaviors and coincident STDs should be sought after. This infection 
is detected in approximately three quarters of the infected women's male sex partners [18]. 
For better cure rates, sexual partners should be treated simultaneously even if the infection 
is asymptomatic.
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Trichomonas vaginalis infects squamous epithelial cells through direct contact, producing 
micro‐ulcerations and microscopic bleedings in the vaginal walls and endocervix. In most 
cases, men are asymptomatic, but they transmit the infection to women. As the women's 
columnar epithelium is not affected, trichomonosis is manifest as vaginitis, but not endo-
cervicitis. The simultaneous presence of an endocervicitis should alert the physician to 
check possible coinfections with C. trachomatis or N. gonorrhoeae. Severe infections are usu-
ally treated with nitroimidazole derivatives, but the number of resistant strains is constantly 
growing [19, 20].
The term mycoplasma is used to designate organisms in the Mollicutes class, the smallest 
free‐living cell‐wall‐deficient microorganisms, the most simple life forms capable of replica-
tion outside a host cell. Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma genitalium and 
Mycoplasma hominis are the most common species of mycoplasmas in both men and women. 
Mycoplasma species (U. urealiticum and M. hominis in particular) are frequently detected in 
sexually active asymptomatic youngsters. However, they can induce a broad spectrum of 
pathological conditions in both women and men, including unexplained chronic symptoms 
of lower urinary tract, NGU, PID, pyelonephritis, chronic prostatitis, preterm labor and idio-
pathic abortion due to infection of the urogenital bodies [21].
Ureaplasma species are sometimes detected in the commensal bacteria of the lower genital 
tract, so their role among STD is still questioned. Some studies demonstrated that the associa-
tion of Ureaplasma species with NGU depends on the detected species and that U. urealiticum is 
an etiologic agent of NGU, unlike U. parvum. In addition, it is reported that U.  urealyticum can 
cause infections in the lower genital tract and is a pathogen agent of urethritis in males [22]. 
In assessing the role of these microorganisms in producing human diseases, their high preva-
lence among asymptomatic individuals should be taken into consideration.
M. genitalium is a microorganism associated with acute and chronic sexually transmitted non-
gonococcal urethritis in men. Data regarding infections in women suggest that M. genitalium is 
associated with urethritis, cervicitis and PID. According to some authors, individuals with clin-
ically‐significant urethritis, persistent PID or cervicitis should be tested for M.  genitalium [23]. 
As in the case of C. trachomatis, M. genitalium infection is often asymptomatic.
Several authors have reported that these organisms are engaged in women infertility, preterm 
delivery, premature rupture of membranes and chorioamnionitis [24, 25]. In addition, some 
studies present mycoplasma as causative agents of male infertility. It has been reported that 
these infections change various sperm characteristics, such as motility, density or morphol-
ogy, and that antibiotic treatment improves the quality of the sperm [26]. A recent study 
found out that detection rates of M. hominis and U. urealiticum in infertile couples were about 
two times higher than in fertile couples [27].
3. STD detection methods
Chlamydia trachomatis was first isolated from the female genital tract in 1959 [28]. Culture tech-
niques for the isolation of these bacteria were developed since 1965. Microimmunofluorescence 
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tests for seroepidemiological studies and serotyping emerged later. Currently, detection of 
C. trachomatis is accomplished via bacteriological examination or enzyme‐linked immunosor-
bent assay (ELISA) [29].
Due to technical difficulties resulting from the need to inoculate specimens immediately 
after sampling, culture assays present low sensitivity (50%) and are seldom used today in the 
microbiological detection of C. trachomatis.
It is thought that Chlamydia immunoglobulin (IgG) antibodies persist in the body for years 
and therefore are used as markers for C. trachomatis infections [30]. These markers can be 
useful if a previous infection could have produced changes in the reproductive tract, but the 
presence of antibodies is not indicative of an infection present in the body at the time of detec-
tion, so these markers cannot be used in diagnosis.
Today, there are numerous methods available for C. trachomatis diagnosis, but it should be 
underlined that the PCR direct approach is given great interest lately. Also, the quick and 
easy to use loop‐mediated isothermal amplification (LAMP) is often employed in detecting 
C. trachomatis [31]. Molecular biology tests based on gene amplification improved diagnostic 
quality in terms of sensitivity and specificity and are gradually replacing all other techniques 
(cell cultures, antigen tests, molecular hybridization without amplification, etc.). These tech-
niques confirmed the high frequency of asymptomatic infections, their prevalence in women 
and men and evaluation of the frequency of recurrent and/or persistent infections.
In detecting N. gonorrhoeae infections, bacteriological cultures are yet the gold standard 
for diagnosis as they allow further testing of antibiotic susceptibility. Culture assays using 
Thayer‐Martin agar have long been seen as the standard method [32]. Due to difficulties 
in collecting, transferring and storing specimens, these tests exhibit low sensitivity and are 
unsuitable for screening. Although enriched agar cultivation is still widely used for the diag-
nosis of N.  gonorrhoeae infections, recent years have seen extensive usage of NAATs, espe-
cially in detecting carriers. These genetic tests enable establishing a diagnosis in 2–3 days for 
gonococcal urethritis or cervicitis with a sensitivity of up to 99%. In contrast, cell cultures 
provide a sensitivity of 85–95% in acute urethral infections and below 50% in chronic forms 
in women. These figures largely depend on sampling conditions, as N. gonorrhoeae is a rather 
fragile organism [33].
Precise diagnosis of gonorrhea is needed to prevent severe complications and to control trans-
mission, especially in the case of asymptomatic infections. Molecular approaches such as 
hybridization assays or nucleic acid amplification tests have revolutionized the diagnosis of 
gonococcal infection due to their increased accuracy compared to the culture media and their 
ability to simultaneously test multiple species. NAAT should be the technique of choice in the 
diagnosis of coinfections and screening. In addition to diagnostic, molecular approaches have 
been successfully applied for testing N. gonorrhoeae in tracking genetic diversity.
Suspicion of T. vaginalis is often considered by clinicians in symptomatic women presenting 
a combination of vaginal discharge, vulvar irritation and unpleasant smell. Unpleasant smell 
and low irritation is more likely to be correlated with bacterial vaginosis than with tricho-
monosis, the irritation being more prominent in the latter case. After completing the physical 
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examination, it is useful to determine the pH of the vaginal secretion. Vaginal pH is higher 
than 4.7 in most women presenting trichomonosis, but high pH values are also seen in most 
women with bacterial vaginosis, therefore further investigations are required for an accurate 
diagnosis. A final diagnosis is based on the positive detection of this parasite. This can be 
determined microscopically in saline serum, using a magnification of 400×, but the sensitiv-
ity of this method is about 60%. A crucial step in the infection process involves a dramatic 
morphological change in the parasite. Free ovoid cells that resemble the familiar image of a 
flagellated protozoan take an amoeboid shape in contact with the urogenital tract [34], mak-
ing microscopic detection more difficult. Pap smears can detect Trichomonas infections, but 
the Gram staining is useless here. Microscopic evaluation is time consuming and standardiza-
tion in the interpretation of positive results is rather ambiguous [18]. Another disadvantage 
is that the microscopic examination should be performed within the first 10 min after sample 
collection [35].
Microscopic examination of the smear and/or culture is presently the most commonly used 
method in the detection of T. vaginalis. Because of its very slow growth rate, strict require-
ments for nutrients and specific culture embodiments that are not widely available, T. vagi-
nalis is difficult to be grown in culture media [36]. Not only are such media very expensive, 
they also present a low sensitivity compared to the PCR methods recently introduced and 
require microscopic evaluation. Another disadvantage is that in women T. vaginalis is unde-
tectable several months after metronidazole therapy [37]. Therefore, a precise diagnosis in 
women and men based on cell cultures is rather difficult to be made and the newer molecular 
techniques are more and more brought into action [38]. In the last decade, several PCR assays 
were developed and studies comparing the two methods in the detection of T. vaginalis dem-
onstrated a higher sensitivity and specificity on behalf of the PCR.
The contribution of flow cytometry technology in investigating adhesion of the extracel-
lular parasite to human host cells has been clearly demonstrated. This methodology can 
be optimized and the test can be used in a format in which several different strains may be 
analyzed simultaneously [39]. It is, however, a difficult method for the diagnosis of tricho-
mooasis. A recent study [40] indicated the advantages of using DNA in the detection of 
T. vaginalis.
As mentioned above, U. urealyticum, U. parvum, M. hominis and M. genitalium are the most 
common mycoplasma species in both men and women. While the first three can be grown 
in culture media, the latter cannot. However, growing on culture embodiments is difficult 
and lasts longer, up to 4 days for U. urealyticum [36]. Also, the technique requires biochemi-
cal identification to determine the species of mycoplasma involved. Mycoplasmas are hard 
to grow in normal laboratory conditions, their simplistic genome demanding more complex 
environments. Difficulties in their cultivation and identification in clinical samples that often 
contain other bacteria or fungi have further complicated causal diagnosis and their asso-
ciation to disease. Mycoplasma infections are often associated with the presence of asymp-
tomatic carriers that may or may not develop the disease [41]. Thus, identification of the 
virulence factors in mycoplasma has been complicated by the difficulties encountered in iso-
lating the strains.
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M. genitalium detection using culture cells is no longer employed in routine clinical practice 
because its growth takes several weeks and presents technical difficulties [42]. According to 
some authors, M. genitalium requires a special medium and incubating for up to 8 weeks to be 
successfully detected [43]. Although many researchers would rather turn to serological meth-
ods when documenting an infection caused by these bacteria [44], such diagnosis approach is 
not appropriate due to cross‐reactivity with M. pneumoniae. For a precise diagnosis, a direct 
identification is therefore recommended.
The safe detection of M. genitalium and other bacteria was for a long time hampered by the 
absence of a commercially available diagnostic test. In recent years, however, NAATs rev-
olutionized the detection and study of mycoplasma. These techniques contributed greatly 
to the DNA‐based improvement of the detection, identification and serotyping methods 
[45]. In addition, the DNA‐based method enabled the identification as separate species of 
U. urealyticum and U. parvum, previously considered as biovariants (biovar 1 and biovar 2) of 
U.  urealyticum [46].
Over 50 mycoplasma genome sequences are now available in public databases, revealing a 
genetic diversity more complex than first predicted. This growing set of data is extremely 
valuable in the study of organisms otherwise difficult to cultivate, offering new means for 
testing and molecular diagnostics [47].
4. Multiplex PCR methods as diagnostic tools for STDs
Multiplex PCR methods for the simultaneous diagnosis of several STDs are more and more 
often employed in recent years. These methods place a number of primer pairs corresponding 
to specific DNA sequences of various STD pathogens all in one reaction tube, such commercial 
ready to use kits being available. While some kits can simultaneously detect two commonly 
associated STDs, such as C. trachomatis and N. gonorrhoeae infections, others can manage three 
pathogen detections. However, kits containing the primer pairs needed for the simultaneous 
detection of 6–12 STD pathogens are gaining momentum on the market. The most effective 
and widely used kits are presently those simultaneously detecting the top six most frequent 
STD agents, namely C. trachomatis, N. gonorrhoeae, T. vaginalis, U. urealyticum, M. hominis and 
M. genitalium, agents which play hard to get for other detection methods and often exhibit 
multiple associations.
Another asset is that easily collectable urine samples are adequate DNA sources for these PCR 
techniques along with the urethral/vaginal discharge swabs. About 30–50 mL of first void 
urine (FVU) samples collected in sterile polypropylene containers early in the morning, at 
least 4 h after the previous urination, are more than enough for a successful analysis. FVU is 
definitely less invasive compared to the harvesting of vaginal or urethral secretions, an aspect 
reported to have influenced a significant number of subjects to avoid STD identification tests 
previously [48]. As urine specimens can be self‐collected in intimacy, an increased number 
of patients tend to favor such option that also enhances the applicability of the screening 
programs [49]. The fact that urethral secretions were found to present increased sensitivity 
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and specificity compared to FVU in immunological analyzes for male subjects seems to hold 
lesser relevance, anyway differences have diminished since NAAT were first performed [46]. 
Concerning the female subjects, the use of urine specimens in STD identification produced 
similar results to vaginal or endocervical secretions [50]. It is known that assay sensitivity may 
decrease if samples are repeatedly frozen/thawed or stored for longer periods of time because 
nucleic acids can easily degrade. Urine samples hold another advantage as well: they can be 
stored at 4–8°C up to 7 days prior to the processing.
Thanks to this easy and noninvasive sampling, the multiplex PCR can be used to detect STDs 
in both symptomatic and asymptomatic individuals and could prove to be a useful screening 
tool for the general population.
A 15 min centrifugation at 15,000g and subsequent supernatant removal and pellet resuspen-
sion are needed as a successful DNA extraction requires concentrated pathogen suspensions. 
Both urethral/vaginal discharge swab specimens and urine samples should be brought to 
room temperature prior to the centrifugation. One can use up to 10 mL amounts of sample 
to increase the DNA extraction yield. Several commercially available kits for DNA extrac-
tion can be used according to the manufacturer's instructions, e.g., QIAamp® DNA Mini Kit 
(Qiagen, Hilden, Germany), AccuPrep Genomic DNA Extraction Kit (Bioneer, Seoul, Korea) 
or MasterPure™ Complete DNA and RNA Purification Kits (Epicentre Biotechnologies, USA).
In our marketing era, such new techniques and gadgets (kits) need to be accompanied by 
studies assessing their performance compared to other traditional methods.
One such study conducted in 2010 [36] compared the multiplex PCR assay for the simul-
taneous detection of T. vaginalis, U. urealyticum and M. hominis with data obtained using 
microscopic and culture techniques. Three cotton swabs were obtained from each of the 
240 women enrolled in the study based on claims of lower genital tract infections. For the 
detection of T. vaginalis, swabs were inoculated in a modified Diamond's Trypticase‐yeast 
medium including fetal bovine serum, streptomycin, penicillin G and amphotericin B and a 
wet mount was prepared for its detection by direct microscopic examination. The samples 
were incubated at 37°C in carbon dioxide atmosphere and observed for a week under a light 
microscope. The presence of M. hominis and U. urealyticum was assessed by culture detection 
using the Mycoplasma Duo kit (Sanofi Diagnostic). A number of different primer sets were 
synthesized, PCR amplifications and ethidium bromide detections in 1% agarose gels were 
performed for a multiplex PCR to be designed for the simultaneous detection of T. vagina-
lis, M. hominis and U. urealyticum. Results were then favorably compared to more conven-
tional methods for the detection of T. vaginalis, M. hominis and U. urealyticum. When tested 
on vaginal swabs, the multiplex PCR correctly detected 14 out of 14 T. vaginalis‐positives, 
95 of 98 U. urealyticum‐positives and 22 out of 22 M. hominis‐positive samples. In contrast, the 
microscopic detection of T. vaginalis exhibited a 28.6% sensitivity, whereas culture methods 
identified 71.4% of the trichomonad infections documented with multiplex PCR. While the 
kit's sensitivity in the detection of U. urealyticum was 96.9%, a value comparable to culture 
test sensitivity (91.8%), identification of M. hominis was greatly improved (100 vs. 36.3% sen-
sitivity). The study argued for multiplex PCR superiority in terms of sensitivity and rapidity 
(hours vs. days/weeks).
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Another study [43] in 2011 compared the results of 113 STD patients tested for six sexu-
ally transmitted microorganisms (C. trachomatis, M. hominis, M. genitalium, N. gonorrhoeae, 
T. vaginalis and genital Ureoplasma) with an automated Seeplex® (Seegene, Korea) multiplex 
PCR‐based STD6B autocapillary electrophoresis (ACE) system vs. culture and conventional 
PCR‐based tests on genital and urinary specimens. C. trachomatis was cultured on cyclohexi-
mide‐treated McCoy cells, while A7, arginine broth and agar media were used for M. hominis 
and Ureaplasma. Conventional culture media were employed for N. gonorrhoeae. N. gonorrhoeae 
and C. trachomatis was also tested with the PCR‐based COBAS Amplicor. On the other hand, 
in‐house validated PCR assays were performed for T. vaginalis, N. gonorrhoeae and C. tracho-
matis, while a Hy‐Mycoplasma PCR Detection Kit (Hy‐Labs, Israel) enabled the detection of 
M. hominis, M. genitalium and Ureaplasma. All six pathogens (T. vaginalis, M. hominis, M. geni-
talium, C. trachomatis, N. gonorrhoeae and Ureaplasma) were subjected to a multiplex PCR 
amplification and the products were separated and detected via automated capillary gel elec-
trophoresis. The sensitivity of the STD6B ACE kit was 100% in case of C. trachomatis, N. gonor-
rhoeae, M. genitalium, T. vaginalis and M. hominis, and 98% for the Ureaplasma. Specificity was 
also 100% for C. trachomatis, N. gonorrhoeae, M. genitalium and T. vaginalis, while for M. hominis 
and Ureaplasma figures were 99 and 97%, respectively. These results prove beyond any doubt 
that the integrated STD6B ACE system is highly effective in the detection of each of the six 
STD pathogens depicted from a single specimen.
Seeplex® STD6 ACE Detection kit (Seegene, Korea) was evaluated in yet another Korean 
study, completed in 2012, which was conducted on 739 subjects [51]. Cervical swabs were 
collected from the women enrolled, while men were requested to provide 30–40 mL of FVU. 
The six pairs of dual priming oligonucleotide primers specifically targeting the C. tracho-
matis, M. hominis, M. genitalium, N. gonorrhoeae, T. vaginalis and U. urealyticum genes were 
tested against a combined monoplex PCR. All specimens were tested with the multiplex 
PCR for the six pathogens and amplification products were separated with a LabChip® DX 
Seeplex® assay system (Caliper, USA). All specimens were retested with six monoplex PCRs 
(one for each of the STD agents) and a duplex strand displacement amplification (SDA) for 
C. trachomatis and N. gonorrhoeae was accomplished with a BD ProbeTec™ (Becton–Dickinson 
Microbiology System, USA). An absolute correlation between the multiplex and monoplex 
PCRs was found in terms of both sensitivity and specificity. The results of the multiplex 
PCR and duplex SDA were 99.7% concordant in the case of C. trachomatis and 100% for 
N. gonorrhoeae. The results confirmed that the simultaneous detection of several species in 
one sample was feasible and that the clinical sensitivity provided by the multiplex PCR was 
on an equal footing with the monoplex PCR and duplex SDA, proving to be fully adequate 
for routine detection of several STDs while holding an upper hand in terms of cost‐effective-
ness and rapidity.
Anyplex™ II STI‐7 Detection Kit (Seegene, Korea) was tested to the limit in a 2013 Korean 
study [46] aiming to investigate the accuracy and reliability of a real‐time multiplex PCR assay 
employed for the detection of seven STD agents (C. trachomatis, N. gonorrhoeae, T. vaginalis, 
M. genitalium, M. hominis, U. urealyticum and U. parvum) in clinical samples. A total of 897 spec-
imens (696 FVU and 201 endocervical swabs) were collected from 365 symptomatic patients 
and 532 asymptomatic volunteers and five diagnostic methods were employed as the speci-
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mens were subjected to parallel testing using four NAATs and one Mycoplasma detection kit. 
The RT‐PCR amplification was performed for all seven microorganisms with Anyplex™ II STI‐7 
Detection Kit. PCR amplification was performed using the Seeplex® STD6 ACE Detection Kit, 
in accordance with the manufacturer's protocol. A battery of kits were deployed for detect-
ing the pathogens: C. trachomatis and N. gonorrhoeae—SDA technology using BD ProbeTec™; 
T. vaginalis and M. genitalium—AmpliSens® (EPH PCR Kit‐InterLabService Ltd, Russia); 
M. hominis and U. urealyticum—Mycoplasma IST 2 Kit (bioMérieux, France). Test sensitivity 
and specificity of each method for every STD agent were calculated in parallel and conclu-
sions were that the multiplex real‐time PCR (Anyplex™ II) demonstrated outstanding results 
compared with other diagnostic tools as it yielded 100% sensitivity and very high specificity 
in the detection of C. trachomatis, N. gonorrhoeae, T. vaginalis, M. genitalium and M. hominis and 
was also useful in discriminating between U. urealyticum and U. parvum. Despite the increased 
workload and higher costs due to the larger number of tests conducted, multiplex real‐time 
PCR was found to be equivalent or superior to other assessment methods and in the future is 
expected to become a standard diagnostic tool.
We ourselves have used a Seeplex® STD6 ACE Detection kit in a study on 224 Romanian 
subjects including persons with STD symptoms and asymptomatic individuals involved in 
unprotected sex with multiple partners, couples experiencing unexplained infertility or oth-
ers requesting STD screening for various reasons. Each individual contributed with 30–50 mL 
FVU samples and DNA extraction was accomplished with MasterPure™ Complete DNA and 
RNA Purification Kits (Epicentre Biotechnologies, USA). A 2% agarose gel containing ethid-
ium bromide was used with 0.5× Tris‐borate 0.1 mM EDTA (TBE) as running buffer. The PCR 
products were visualized using a UV transilluminator. An example of gel electrophoresis 
results can be visualized in Figure 1.
The accuracy of the method was demonstrated by the lack of contamination (no amplicons 
in the negative control band) and the presence of positive control bands corresponding to all 
six DNA fragments of known molecular weight included in the marker used to determine the 
size of the amplification products. Also, internal controls indicated proper PCR amplification 
in each microtube (see Figure 1).
About 74 (33.03%) of the 224 subjects, both symptomatic and asymptomatic, were positive 
for one or more STDs. All six pathogen agents were detected with the multiplex PCR kit, 
several double or triple infections demonstrating associative patterns. The following double 
associations were detected in the study: C. trachomatis and N. gonorrhoeae, C. trachomatis and 
U. urealyticum, N. gonorrhoeae and U. urealyticum, C. trachomatis and M. hominis. Several triple 
infections grouped C. trachomatis, N. gonorrhoeae and U. urealyticum.
The bacteria most frequently identified in the analyzed urine samples was C. trachomatis, 
found in 20.9% of the cases. Consequently, a number of associations between C.  trachomatis 
and other STD agents (N. gonorrhoeae, U. urealyticum and M. hominis, respectively) were 
found. These results are consistent with studies conducted in other countries or international 
statistics indicating C. trachomatis as the most common STD agent [4, 52, 53]. Detection of 
C.  trachomatis in several asymptomatic patients demonstrated again how easily this infection 
can pass unnoticed.
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Some studies recommended that all sexually active women should be tested, pregnant 
ones or those that have experienced miscarriages in particular, given the high prevalence of 
C. trachomatis/N. gonorrhoeae infections [54, 55]. In the US, concomitant empiric treatment of 
C. trachomatis and N. gonorrhoeae is recommended for all gonorrhea positives considering the 
frequent association between the two pathogens [56]. However, results indicate that several 
other associations (such as those between C. trachomatis and U. urealyticum or M. hominis) are 
often encountered, suggesting that a population screening for C. trachomatis/N. gonorrhoeae is 
not good enough and a multiplex method for the simultaneous detection of the most frequent 
six or more STD agents would be more appropriate, considering the different associations 
that may arise.
N. gonorrhoeae was detected in 7.1% of the cases, as was the case of U. urealyticum. These results 
are consistent with other studies indicating a high prevalence of both bacteria, the most fre-
quent STD agents except for C. trachomatis [9, 57]. A notable finding is that we detected patients 
positive to N. gonorrhoeae that presented no or very atypical symptoms of gonococcal infec-
tion, which could have resulted in inadequate treatment without this DNA‐based analysis 
that allowed us to identify the presence of the gonococcus. The N. gonorrhoeae/U. urealyticum 
coinfection we found was another confirmation that both C. trachomatis and N. gonorrhoeae can 
associate with other STD pathogens, an additional argument for the use of multiplex kits able 
to detect a large number of STDs in the same sample.
Figure 1. STD pathogens—agarose gel electrophoresis. NC: negative control, 177–186: samples, PC: positive control, MK: 
marker, TV: T. vaginalis, MH: M. hominis, MG: M. genitalium, CT: C. trachomatis, NG: N. gonorrhoeae, UU: U. Urealyticum.
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A recent study in Korea [58] found a 3.3% infection rate for T. vaginalis in the general popula-
tion and argued that the rate was higher in women over 50 years of age. This followed a previ-
ous study documenting a 2.4% infection rate for T. vaginalis in the same area 15 years before 
and the significant increase lead researchers to recommend PCR‐based testing of T. vaginalis 
in all women over 50 years old, irrespective of their symptomatology. Our study detected but 
one (0.44%) case of T. vaginalis infection, suggesting that in our area prevalence is much lower 
than the literature data based on other than NAAT determinations (e.g., physical and micros-
copy examinations or cell cultures) indicated. NAAT seems to be for now the only accurate 
method to diagnose this parasite. Our results are consistent with those conducted in other 
countries where T. vaginalis was detected in similarly low percentages compared to other 
STD [43, 51]. However, the incidence of trichomonosis has gradually decreased over the past 
40 years. This may be due to the large amount of metronidazole and other imidazoles gener-
ally used in the treatment of bacterial vaginosis. Although the number of people infected with 
T. vaginalis is low, the analysis is justified considering its asymptomatic manifestation and the 
serious complications it produces.
In a study conducted in the United States, M. hominis and various Ureaplasma species were 
detected in 21–53% of the cases involving asymptomatic women and 40–80% of the sexually 
active women, respectively, their prevalence being slightly lower in men [59]. In our study, myco-
plasma infections were detected in 25 individuals (a rate of 11.1%), the most commonly encoun-
tered being U. urealyticum (in 7.1% of the patients). Although M. hominis and M.  genitalium were 
less represented (1.7 and 2.2% of the patients, respectively), these infections cannot be ignored. 
More so considering that M. genitalium was detected in an asymptomatic patient previously 
found negative for different STDs investigated on specific culture media (including ones for 
M. genitalium) in a number of different specimens (urine, urethral discharge). This last example 
reaffirmed the sensitivity of the multiplex PCR method over traditional alternatives.
5. Advantages of the multiplex PCR method
The advantages of the multiplex PCR method were assessed by various researchers  comparing 
the diagnosis results obtained with different other conventional methods. The sensitivity and 
specificity of these methods were analyzed on different specimens in comparison to tradi-
tional methods, some of these considered to be the gold standard in diagnosis [36, 43, 46, 51]. 
Although this method can sometimes increase the workload, implying more protocol steps 
(DNA extraction, purification—if necessary, PCR amplification, electrophoresis), it still holds a 
huge advantage in terms of the exact diagnosis of STD. Except for special circumstances, such as 
when testing susceptibility to antibiotics of the various bacterial agents, NATTs have become the 
most sought after tests in STD detection. Regarding bacterial resistance to antibiotics, the DNA 
extracted and identified as belonging to such bacteria may be genetically tested to determine the 
genes that induce resistance to antibiotics or the different mutations that cause such resistance.
Although the symptoms are often similar, the treatment may differ depending on the STD 
agent detected. Without an accurate diagnosis, treatment is often ineffective. Clinicians often 
employ point‐of‐care (POC) tests to diagnose vaginal infections and STDs. For example, most 
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clinicians rely on Amsel's clinical criteria in defining bacterial vaginosis: increased vaginal 
pH, the presence of amines, clue cells observed on wet mounts and homogeneous vaginal 
secretions [60]. Although bacterial cultures and other methods are still widely used in STD 
detection, PCR tests are relevant, reproducible, sensitive and specific enough tools imply-
ing low costs and simplicity. In addition, the availability of commercial NAATs that include 
several STD pathogens allows more detailed studies regarding the relationship between such 
organisms in the etiology of these diseases. As well documented, all STDs occur in popula-
tions at high risk for other sexually transmitted infections. Their presence in a given indi-
vidual is a marker for high‐risk behaviors and coincidental infections should be sought after, 
as well as other more serious sexually transmitted diseases such as HIV.
An advantage of this method is its great sensitivity consisting in the detection of STD patho-
gens in individuals who have previously been tested with conventional methods and came 
out with negative results.
The greatest advantage of this method is the detection of double or multiple coinfections. 
This is an important argument for promoting multiplex testing in the same sample. These 
results could have important implications in epidemiology and treatment by improve-
ments in the accuracy of determining the possible synergies and interactions between such 
microorganisms.
STD screening for certain categories of population (e.g., patients attending sexual health 
clinics, infertile persons or women who had miscarriages) is necessary not only to identify 
symptomatic persons in order to diagnose and treat their infection but also to identify asymp-
tomatic individuals who serve as possible infection carriers in order to reduce morbidity and 
help controlling these STDs. The multiplex PCR method provides a good opportunity to 
argue for STD screening.
Author details
Mihaela L. Vică1*, Horea V. Matei1 and Costel V. Siserman2
*Address all correspondence to: mvica@umfcluj.ro
1 Department of Cell and Molecular Biology, “Iuliu Hatieganu” University of Medicine and 
Pharmacy, Cluj‐Napoca, Romania
2 Department of Legal Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy 
Cluj‐Napoca, Romania
References
[1] Holmes K.K., Handsfield H.H. Sexually transmitted diseases: overview and clinical 
approach. In: Harrison’s Principles of Internal Medicine. 14th ed. Bucuresti: Teora; 2003. 
p. 881–893.
The Advantages of Using Multiplex PCR for the Simultaneous Detection of Six Sexually Transmitted Diseases
http://dx.doi.org/10.5772/65901
95
[2] Salah R.M., Allam A.M., Magdy A.M., Mohamed A.S. Bacterial vaginosis and infertility: 
cause or association?. Eur J Obstet Gynecol Reprod Biol. 2013;167(1):59–63. doi: 10.1016/j.
ejogrb.2012.10.031
[3] Korenromp E.L., White R.G., Orroth K.K., Bakker R., Kamali A., Serwadda D., et al. 
Determinants of the impact of sexually transmitted infection treatment on prevention of 
HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka interven-
tion trials. J Infect Dis. 2005;191(1):168–178. doi: 10.1086/425274
[4] ECDC.Annual epidemiological report on communicable diseases in Europe. Stockholm: 
European Centre for Disease Prevention and Control. 2010
[5] McGregor J.A., French J.I. Chlamydia trachomatis infection during pregnancy. Am J Obstet 
Gynecol. 1991;164(6):1782–1789. doi:10.1016/0002‐9378(91)90560‐E
[6] Witkin S.S., Linhares I.M. Chlamydia trachomatis in subfertile women undergoing uterine 
instrumentation. Hum Reprod. 2002;17(8):1938–1941
[7] Hafner L.M., McNeilly C. Vaccines for Chlamydia infections of the female genital tract. 
Future Microbiol. 2008;3(1):67–77. doi:10.2217/17460913.3.1.67
[8] Anaes. Evaluation of screening low urogenital Chlamydia trachomatis in France. Paris: 
National Accreditation and Health Evaluation Agency. 2003
[9] World Health Organization (WHO). Prevalence and incidence in 2005 of selected sexu-
ally transmitted infections. In: Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and 
Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. 
WHO, Geneva. 2011
[10] Li S.Y. Global transmission of multiple‐drug resistant Neisseria gonorrhoeae strains refrac-
tive to cephalosporin treatment. J Formos Med Assoc. 2012;111(9):463–464. doi:10.1016/j.
jfma.2012.03.004
[11] Querci M., Rombini F., Spinola L., Boutureira M., Yetman M., Reyes D., et al. 
Neisseria gonorrhoeae infective endocarditis. A case report. Int J Antimicrob Ag 41S1. 
2013;S1–S34:P53.
[12] Toyer A.L., Trignol‐Viguier N., Mereghetti L., Joly B., Blin E., Body G., et al. Interest 
of simultaneous Chlamydia trachomatis and Neisseria gonorrhoeae screening at the 
time of preabortion consultation. Contraception. 2012;86:572–576. doi:10.1016/j.
contraception.2012.04.012
[13] Gilbert R.O., Elia G., Beach D.H., Klaessig S., Singh B.N. Cytopathogenic effect of 
Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun. 
2000;68(7):4200–4206.
[14] Cudmore S.L., Garber G.E. Prevention or treatment: the benefits of Trichomonas vaginalis 
vaccine. J Infect Public Health. 2010;3(2):47–53. doi:10.1016/j.jiph.2010.01.003
Polymerase Chain Reaction for Biomedical Applications96
[15] Cotch M.F., Pastorek J.G., Nugent R.P., Hillier S.L., Gibbs R.S., Martin D.H., et al. 
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal 
Infections and Prematurity Study Group. Sex Transm Dis. 1997;24(6):353–360.
[16] Noël J.C., Fayt I., Munoz M.R.R., Simon P., Engohan‐Aloghe C. High prevalence of high‐
risk human papillomavirus infection among women with Trichomonas vaginalis infec-
tion on monolayer cytology. Arch Gynecol Obstet. 2010;282(5):503–505. doi:10.1007/
s00404‐009‐1291‐x
[17] Mayer K.H., Bush T., Henry K., Overton E.T., Hammer J., Richardson J., et al. Ongoing 
sexually transmitted disease acquisition and risk‐taking behavior among US HIV‐
infected patients in primary care: implications for prevention interventions. Sex Transm 
Dis. 2012;39(1):1–7. doi:10.1097/OLQ.0b013e31823b1922
[18] Seña A.C., Miller W.C., Hobbs M.M., Schwebke J.R., Leone P.A., Swygard H., et al. 
Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treat-
ment, and prevention. Clin Infect Dis. 2007;44(1):13–22. doi: 10.1086/511144
[19] Pal C., Bandyopadhyay U. Redox‐active antiparasitic drugs. Antioxid Redox Signal. 
2012;17(4):555–582. doi:10.1089/ars.2011.4436
[20] Sobel J.D., Nagappan V., Nyirjesy P. Metronidazole‐resistant vaginal trichomo-
niasis—an emerging problem. N Engl J Med. 1999;341(4):292–293. doi:10.1056/
NEJM199907223410417
[21] Baka S., Kouskouni E., Antonopoulou S., Sioutis D., Papakonstantinou M., Hassiakos D., 
et al. Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in women with 
chronic urinary symptoms. Urology. 2009;74(1):62–66. doi: 10.1016/j.urology.2009.02.014
[22] Wetmore C.M., Manhart L.E., Lowens M.S., Golden M.R., Whittington W.L., Xet‐Mull 
A.M., et al. Demographic, behavioral, and clinical characteristics of men with non-
gonococcal urethritis differ by etiology: a case‐comparison study. Sex Transm Dis. 
2011;38(3):180–186. doi:10.1097/OLQ.0b013e3182040de9
[23] Manhart L.E., Holmes K.K., Hughes J.P., Houston L.S., Totten P.A. Mycoplasma genita-
lium among young adults in the United States: an emerging sexually transmitted infec-
tion. Am J Public Health. 2007;97(6):1118–1125. doi: 10.2105/AJPH.2005.074062
[24] Gupta A., Gupta A., Gupta S., Mittal A., Chandra P., Gill A.K. Correlation of myco-
plasma with unexplained infertility. Arch Gynecol Obstet. 2009;280(6):981–985. doi: 
10.1007/s00404‐009‐1042‐z
[25] Taylor‐Robinson D. The role of mycoplasmas in pregnancy outcome. Best Pract Res Clin 
Obstet Gynaecol. 2007;21(3):425–438. doi:10.1016/j.bpobgyn.2007.01.011
[26] Reichart M., Kahane I., Bartoov B. In vivo and in vitro impairment of human and ram 
sperm nuclear chromatin integrity by sexually transmitted Ureaplasma urealyticum infec-
tion. Biol Reprod. 2000;63(4):1041–1048.
The Advantages of Using Multiplex PCR for the Simultaneous Detection of Six Sexually Transmitted Diseases
http://dx.doi.org/10.5772/65901
97
[27] Lee J.S., Kim K.T., Lee H.S., Yang K.M., Seo J.T., Choe J.H. Concordance of Ureaplasma 
urealyticum and Mycoplasma hominis in infertile couples: impact on semen parameters. 
Urology. 2013;81(6):1219–1224. doi: 10.1016/j.urology.2013.02.044
[28] Mirdh P.A., Paavonen J., Puolakkainen M, editors. Chlamydia. New York: Plenum Press 
Publishing Co; 1989.
[29] Bianchi A. Chlamydia trachomatis et Chlamydia pneumoniae: diagnostic problems. Med Mal 
Infect. 1999;29(Suppl. 1):38–50.
[30] Mol B.W., Dijkman B., Wertheim P., Lijmer J., van der Veen F., Bossuyt P.M. The accu-
racy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta‐analy-
sis. Fertil Steril. 1997;67(6):1031–1037.
[31] Dhama K., Karthik K., Chakraborty S., Tiwari R., Kapoor S., Kumar A., et al. Loop‐medi-
ated isothermal amplification of DNA (LAMP): a new diagnostic tool lights the world of 
diagnosis of animal and human pathogens: a review. Pak J Biol Sci. 2014;17(2):151–166.
[32] Van Dyck E., Ieven M., Pattyn S., Van Damme L., Laga M. Detection of Chlamydia 
trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three 
nucleic acid amplification tests. J Clin Microbiol. 2001;39(5):1751–1756. doi: 10.1128/
JCM.39.5.1751‐1756.2001
[33] Whiley D.M., Tapsall J.W., Sloots T.P. Nucleic acid amplification testing for Neisseria 
gonorrhoeae: an ongoing challenge. J Mol Diagn. 2006;8(1):3–15. doi: 10.2353/
jmoldx.2006.050045
[34] Gould S.B., Woehle C., Kusdian G., Landan G., Tachezy J., Zimorski V., et al. Deep sequenc-
ing of Trichomonas vaginalis during the early infection of vaginal epithelial cells and 
amoeboid transition. Int J Parasitol. 2013;43(9):707–719. doi:10.1016/j.ijpara.2013.04.002
[35] Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment 
issues. BMC Infect Dis. 2015;15(1):307. doi:10.1186/s12879‐015‐1055‐0
[36] Diaz N., Dessì D., Dessole S., Fiori P.L., Rappelli P. Rapid detection of coinfections by 
Trichomonas vaginalis, Mycoplasma hominis, and Ureaplasma urealyticum by a new multiplex 
polymerase chain reaction. Diagn Microbiol Infect Dis. 2010;67(1):30–36. doi:10.1016/j.
diagmicrobio.2009.12.022
[37] Gatski M., Mena L., Levison J., Clark R.A., Henderson H., Schmidt N., et al. Patient‐deliv-
ered partner treatment and Trichomonas vaginalis repeat infection among human immu-
nodeficiency virus‐infected women. Sex Transm Dis. 2010;37(8):502–505. doi:10.1097/
OLQ.0b013e3181d891fc
[38] Hobbs M.M., Lapple D.M., Lawing L.F., Schwebke J.R., Cohen M.S., Swygard H., et al. 
Methods for detection of Trichomonas vaginalis in the male partners of infected women: 
implications for control of trichomoniasis. J Clin Microbiol. 2006;44(11):3994–3999. 
doi:10.1128/JCM.00952‐06
Polymerase Chain Reaction for Biomedical Applications98
[39] Brooks A.E., Parsamand T., Kelly R.W., Simoes‐Barbosa A. An improved quantitative 
method to assess adhesive properties of Trichomonas vaginalis to host vaginal ectocer-
vical cells using flow cytometry. J Microbiol Methods. 2013;92(1):73–78. doi:10.1016/j.
mimet.2012.10.011
[40] de Waaij D.J., Ouburg S., Dubbink J.H., Peters R.P.H., Morre S.A. Evaluation of Prestoplus 
assay and LightMix kit Trichomonas vaginalis assay for detection of Trichomonas vaginalis in 
dry vaginal swabs. J Microbiol Meth. 2016;127:102–104. doi:10.1016/j.mimet.2016.06.002
[41] Waites K.B., Talkington D. New developments of human diseases due to mycoplasmas. 
In: Blanchard A., Browning G., editors. Mycoplasmas: molecular biology, pathogenicity 
and strategies for control. Horizon bioscience; 2005. p. 289–354.
[42] Ross J.D., Jensen J.S. Mycoplasma genitalium as a sexually transmitted infection: impli-
cations for screening, testing, and treatment. Sex Transm Infect. 2006;82(4):269–271. 
doi:10.1136/sti.2005.017368
[43] Samra Z., Rosenberg S., Madar‐Shapiro L. Direct simultaneous detection of 6 sexually 
transmitted pathogens from clinical specimens by multiplex polymerase chain reac-
tion and auto‐capillary electrophoresis. Diagn Microbiol Infect Dis. 2011;70(1):17–21. 
doi:10.1016/j.diagmicrobio.2010.12.001
[44] Baseman J.B., Cagle M., Korte J.E., Herrera C., Rasmussen W.G., Baseman J.G., et al. 
Diagnostic assessment of Mycoplasma genitalium in culture‐positive women. J Clin 
Microbiol. 2004;42(1):203–211.
[45] Barré A., de Daruvar A., Blanchard A. MolliGen, a database dedicated to the compara-
tive genomics of Mollicutes. Nucleic Acids Res. 2004;32:D307–D310. doi: 10.1093/nar/
gkh114
[46] Choe H.S., Lee D.S., Lee S.J., Hong S.H., Park D.C., Lee M.K., et al. Performance 
of Anyplex™ II multiplex real‐time PCR for the diagnosis of seven sexually trans-
mitted infections: comparison with currently available methods. Int J Infect Dis. 
2013;17(12):1134–1140. doi:10.1016/j.ijid.2013.07.011
[47] Citti C., Blanchard A. Mycoplasmas and their host: emerging and re‐emerging minimal 
pathogens. Trends Microbiol. 2013;21(4):196–203. doi: 10.1016/j.tim.2013.01.003
[48] O'Byrne P. Self‐directed sexually transmitted infection testing: providing noninvasive 
sexual health services. Appl Nurs Res. 2011;24(1):17–21. doi: 10.1016/j.apnr.2009.02.005
[49] Ostergaard L. Diagnosis of urogenital Chlamydia trachomatis infection by use of DNA 
amplification. APMIS Suppl. 1999;89:5–36.
[50] Fang J., Husman C., DeSilva L., Chang R., Peralta L. Evaluation of self‐collected vaginal 
swab, first void urine, and endocervical swab specimens for the detection of Chlamydia 
trachomatis and Neisseria gonorrhoeae in adolescent females. J Pediatr Adolesc Gynecol. 
2008;21(6):355–360. doi: 10.1016/j.jpag.2008.03.010
The Advantages of Using Multiplex PCR for the Simultaneous Detection of Six Sexually Transmitted Diseases
http://dx.doi.org/10.5772/65901
99
[51] Lee S.J., Park D.C., Lee D.S., Choe H.S., Cho Y.H. Evaluation of Seeplex® STD6 ACE 
detection kit for the diagnosis of six bacterial sexually transmitted infections. J Infect 
Chemother. 2012;18(4):494–500. doi:10.1007/s10156‐011‐0362‐7
[52] Sturm‐Ramirez K., Brumblay H., Diop K., Guèye‐Ndiaye A., Sankalé J.L., Thior I., et al. 
Molecular epidemiology of genital Chlamydia trachomatis infection in high‐risk women 
in Senegal, West Africa. J Clin Microbiol. 2000;38(1):138–145.
[53] Krõlov K., Frolova J., Tudoran O., Suhorutsenko J., Lehto T., Sibul H., et al. Sensitive 
and rapid detection of Chlamydia trachomatis by recombinase polymerase amplifi-
cation directly from urine samples. J Mol Diagn. 2014;16(1):127–135. doi: 10.1016/j.
jmoldx.2013.08.003
[54] U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive 
Services Task Force recommendation statement. Ann Intern Med. 2007;147(2):128–134.
[55] U.S. Preventive Services Task Force. Screening for Gonorrhea: recommendation state-
ment. Ann Fam Med. 2005;3(3):263–267. doi:10.1370%2Fafm.337
[56] Stary A., Stary G. Sexually transmitted infection. In: Callen J.P., Cerroni L., Heymann 
W.R., Hruza G., Mancini A.J., Patterson J.W., et al, editors. Dermatology. 3rd ed. Elsevier; 
2012. p. 1379–1383.
[57] Keane F.E., Thomas B.J., Gilroy C.B., Renton A., Taylor‐Robinson D. The association of 
Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial 
vaginosis: observations on heterosexual women and their male partners. Int J STD AIDS. 
2000;11(6):356–360.
[58] Kim S.R., Kim J.H., Gu N.Y., Kim Y.S., Hong Y.C., Ryu J.S. Prevalence of trichomo-
niasis by PCR in women attending health screening in Korea. Korean J Parasitol. 
2016;54(2):187–190. doi:10.3347/kjp.2016.54.2.187
[59] Waites K.B., Katz B., Schelonka R.L. Mycoplasmas and ureaplasmas as neonatal patho-
gens. Clin Microbiol Rev. 2005;18(4):757–789. doi:10.1128/CMR.18.4.757‐789.2005
[60] Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., Holmes K.K. Nonspecific 
vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 
1983;74(1):14–22.
Polymerase Chain Reaction for Biomedical Applications100
